EE9400180A - Peptiidühendid, nende kasutamine, valmistamismeetod ja farmatseutiline segu - Google Patents

Peptiidühendid, nende kasutamine, valmistamismeetod ja farmatseutiline segu

Info

Publication number
EE9400180A
EE9400180A EE9400180A EE9400180A EE9400180A EE 9400180 A EE9400180 A EE 9400180A EE 9400180 A EE9400180 A EE 9400180A EE 9400180 A EE9400180 A EE 9400180A EE 9400180 A EE9400180 A EE 9400180A
Authority
EE
Estonia
Prior art keywords
pct
alpha
preparation
sec
pharmaceutical composition
Prior art date
Application number
EE9400180A
Other languages
English (en)
Inventor
Undheim Kjell
Kremminger Peter
Solbakken Magne
Agner Erik
Lange Meinolf
Original Assignee
Hafslund Nycomed As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929211675A external-priority patent/GB9211675D0/en
Priority claimed from GB929211674A external-priority patent/GB9211674D0/en
Priority claimed from GB929211676A external-priority patent/GB9211676D0/en
Application filed by Hafslund Nycomed As filed Critical Hafslund Nycomed As
Publication of EE9400180A publication Critical patent/EE9400180A/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4722—G-proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/067—Hemoregulatory peptides based on sequence Glp-Glu-Asp-Cys-Lys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EE9400180A 1992-06-02 1994-11-16 Peptiidühendid, nende kasutamine, valmistamismeetod ja farmatseutiline segu EE9400180A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929211675A GB9211675D0 (en) 1992-06-02 1992-06-02 Peptide compounds
GB929211674A GB9211674D0 (en) 1992-06-02 1992-06-02 Peptide compounds
GB929211676A GB9211676D0 (en) 1992-06-02 1992-06-02 Peptide compounds

Publications (1)

Publication Number Publication Date
EE9400180A true EE9400180A (et) 1996-02-15

Family

ID=27266223

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400180A EE9400180A (et) 1992-06-02 1994-11-16 Peptiidühendid, nende kasutamine, valmistamismeetod ja farmatseutiline segu

Country Status (11)

Country Link
US (1) US5610141A (et)
EP (1) EP0673388B1 (et)
JP (1) JPH08501066A (et)
CN (1) CN1086221A (et)
AT (1) ATE172204T1 (et)
AU (1) AU4340393A (et)
DE (1) DE69321605D1 (et)
EE (1) EE9400180A (et)
LV (1) LV10288B (et)
NO (1) NO944669L (et)
WO (1) WO1993024523A1 (et)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL104323A0 (en) * 1992-01-10 1993-05-13 Smithkline Beecham Corp Hemoregulatory peptides
GB9324691D0 (en) * 1993-12-01 1994-01-19 Hafslund Nycomed As Peptide compounds
JP6150726B2 (ja) 2011-03-09 2017-06-21 Jitsubo株式会社 新規な非ペプチド性架橋構造を含む架橋ペプチド、ならびに該架橋ペプチドの合成方法および該方法に用いる新規な有機化合物
US9365615B2 (en) 2013-09-09 2016-06-14 Jitsubo Co., Ltd. Cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method
CN108059663A (zh) * 2018-02-10 2018-05-22 润辉生物技术（威海）有限公司 一种来考诺肽的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4058512A (en) * 1975-04-28 1977-11-15 Ab Kabi Synthetic peptides having growth promoting activity
GB8626539D0 (en) * 1986-11-06 1986-12-10 Nycomed As Peptide compounds
ZW11290A1 (en) * 1989-07-14 1990-10-31 Smithkline Beecham Corp Hemoregulatory peptides

Also Published As

Publication number Publication date
EP0673388A1 (en) 1995-09-27
WO1993024523A1 (en) 1993-12-09
ATE172204T1 (de) 1998-10-15
NO944669D0 (no) 1994-12-02
NO944669L (no) 1994-12-02
DE69321605D1 (de) 1998-11-19
CN1086221A (zh) 1994-05-04
LV10288A (lv) 1994-10-20
LV10288B (en) 1995-04-20
AU4340393A (en) 1993-12-30
EP0673388B1 (en) 1998-10-14
JPH08501066A (ja) 1996-02-06
US5610141A (en) 1997-03-11

Similar Documents

Publication Publication Date Title
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
DE69130741D1 (de) Immunogene peptide, antikörper sowie deren verwendungen im zusammenhang mit der cd4-rezeptorbindung
PL274485A1 (en) Method of obtaining stable preparations of human proteins
DK155318C (da) Indoxyl- og thioindoxyl-aminosyreestere og -peptidestere, diagnostisk middel indeholdende dem, og deres anvendelse i diagnostiske midler
DE69939327D1 (de) Funktionelle antagonisten von hedgehog-aktivität
NO962664D0 (no) Forbindelser med veksthormonfrigjörende egenskaper
TR199901949T2 (xx) Lemfositik t�m�rler i�in �areler.
ES2187782T3 (es) Procedimiento para la produccion de polipeptidos.
DK0572688T3 (da) Peptider, med organ-beskyttende aktivitet, fremgangsmåde til deres fremstilling og deres anvendelse ved terapi
DE69334146D1 (de) Peptide mit gdp-austauschfaktorartiger wirkung, dafür kodierende nukleinsäuresequenzen, ihre herstellung und verwendung
DE3788313D1 (de) Renin-hemmende Di- und Tripeptide, Verfahren zu deren Herstellung, diese enthaltende Mittel und ihre Verwendung.
ATE211391T1 (de) Verwendung von hmg proteinen zur herstellung von arzneimitteln mit zytotoxischer wirkung
HUP9900506A2 (hu) Protrombinszármazékok
LTIP610A (en) Inhibitors of cells proliferation, pharmaceutical composition and method for preparation of compounds
EE9400180A (et) Peptiidühendid, nende kasutamine, valmistamismeetod ja farmatseutiline segu
NO933742L (no) Humant, benavledet, insulinlignende vekstfaktorbindingsprotein
DK639887A (da) Farmaceutiske praeparater
NO944668L (no) Dobbeltkjedete peptidforbindelser med hemoregulatorisk aktivitet
CA2004764A1 (en) Ancrod proteins, their preparation and use
SE9402332D0 (sv) Igf-1
ES531495A0 (es) Procedimiento para preparar un hidrolizado proteinico
ATE174927T1 (de) Haemoregulatorische penta-oder hexapeptide
KR920700224A (ko) 신규의 생리활성 펩티드 및 이를 유효성분으로서 함유한 칼슘대사 조절제
NO944670L (no) Enkeltkjedet peptid med hemoregulatorisk aktivitet
ATE97912T1 (de) Renin-hemmende di- und tripeptide, verfahren zu deren herstellung, diese enthaltende mittel und ihre verwendung.